FDA Rejects Johnson & Johnson's RA Drug Sirukumab, More Safety Data Needed Post author:Sam Post published:September 24, 2017 Post category:BioPharma September 25, 2017By Alex Keown, BioSpace.com Breaking… Source: BioSpace You Might Also Like Bay Area Startup Offers a Compelling Deal to Scientists Hunting for New Drugs April 19, 2017 A Look at the 5 Most Profitable Biopharma Companies June 19, 2017 Hikma's Advair Generic Gets Further Delayed March 11, 2018
